Attached files
| file | filename |
|---|---|
| EX-10.41 - Hancock Jaffe Laboratories, Inc. | ex10-41.htm |
| EX-10.40 - Hancock Jaffe Laboratories, Inc. | ex10-40.htm |
| EX-10.39 - Hancock Jaffe Laboratories, Inc. | ex10-39.htm |
| EX-10.38 - Hancock Jaffe Laboratories, Inc. | ex10-38.htm |
| EX-10.37 - Hancock Jaffe Laboratories, Inc. | ex10-37.htm |
| EX-4.10 - Hancock Jaffe Laboratories, Inc. | ex4-10.htm |
| EX-4.9 - Hancock Jaffe Laboratories, Inc. | ex4-9.htm |
| EX-4.7 - Hancock Jaffe Laboratories, Inc. | ex4-7.htm |
| EX-3.6 - Hancock Jaffe Laboratories, Inc. | ex3-6.htm |
| EX-1.1 - Hancock Jaffe Laboratories, Inc. | ex1-1.htm |
| S-1/A - Hancock Jaffe Laboratories, Inc. | forms-1a.htm |
Independent Registered Public Accounting Firm’s Consent
We consent to the inclusion in this Registration Statement of Hancock Jaffe Laboratories, Inc. on Form S-1 Amendment No. 4 [File No. 333-220372] of our report dated September 6, 2017, except for Note 16, as to which the date is December 14, 2017, which includes an explanatory paragraph as the Company’s ability to continue as a going concern, with respect to our audits of the financial statements of Hancock Jaffe Laboratories, Inc. as of December 31, 2016 and 2015 and for the years ended December 31, 2016 and 2015, which report appears in the Prospectus, which is part of this Registration Statement. We also consent to the reference to our Firm under the heading “Experts” in such Prospectus.
/s/ Marcum LLP
Marcum llp
New York, New York
January 26, 2018